SAB Biotherapeutics Inc. (SABS)
NASDAQ: SABS
· Real-Time Price · USD
2.19
-0.02 (-0.90%)
At close: Aug 15, 2025, 3:59 PM
2.21
0.91%
After-hours: Aug 15, 2025, 07:52 PM EDT
SAB Biotherapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | -410 | 262.73K | 1.21M | 1.51M | 2.78M | 2.6M | 1.66M | 3.51M | 5.84M | 12.1M | 23.91M | 82.62M | 79.03M | 72.68M | 60.88M | n/a | n/a | n/a |
Cost of Revenue | 916.25K | 1.12M | 2.32M | 4.95M | 4.94M | 4.81M | 3.75M | 3.72M | 3.65M | 2.76M | 1.83M | 61.19M | 60.28M | 60.28M | 60.28M | n/a | n/a | n/a |
Gross Profit | -3.27M | -3.21M | -3.47M | -3.44M | -2.16M | -2.2M | -1.16M | 711.91K | 3.11M | 10.27M | 22.07M | 21.43M | 18.41M | 11.8M | -601 | -593K | -257K | n/a |
Operating Income | -41.82M | -42.29M | -42.91M | -51.78M | -45.79M | -42.06M | -38.08M | -27.06M | -29.55M | -29.61M | -28.92M | -33.75M | -26.27M | -22.61M | -15.08M | -2.4M | -2.07M | 804.92K |
Interest Income | 489.61K | 850.6K | 1.29M | 1.63M | 1.37M | 1.02M | 584.97K | 130.85K | 133.87K | 121.13K | 71.07K | 56.01K | 42.4K | 29.47K | 23.95K | 9.08K | 5.32K | 2.42K |
Pretax Income | -37.06M | -34.28M | -34.1M | -45.57M | -40.32M | -39.87M | -42.19M | -27.19M | -29.16M | -27.15M | -18.71M | -28.45M | -21.71M | -19.78M | -19.45M | -1.87M | -1.54M | 1.4M |
Net Income | -37.06M | -34.28M | -34.1M | -45.57M | -40.32M | -39.87M | -42.19M | -27.21M | -29.19M | -27.08M | -18.74M | -28.45M | -25.44M | -23.6M | -23.18M | -5.6M | -1.54M | 1.4M |
Selling & General & Admin | 12M | 11.91M | 11.02M | 23.23M | 22.32M | 22.58M | 23.8M | 11.76M | 13.23M | 14.64M | 16.38M | 30.63M | 30.18M | 28.27M | 26.42M | 9.34M | 5.74M | 3.34M |
Research & Development | 30.11M | 29.92M | 30.39M | 27.05M | 23.24M | 20.1M | 16.52M | 19.36M | 22.69M | 27.61M | 36.4M | 54.98M | 62.7M | 72.8M | 72.25M | 46.53M | 31.46M | 12.78M |
Other Expenses | -1.96M | -1.96M | -1.96M | -1.94M | -1.93M | -2.02M | -2.6M | -3.81M | -6.42M | -12.68M | -23.91M | -83.32M | -94.42M | -106.27M | -111.4M | -49.82M | -35.14M | -16.93M |
Operating Expenses | 40.15M | 39.86M | 39.44M | 48.34M | 43.63M | 39.86M | 36.91M | 26.54M | 28.74M | 29.61M | 28.92M | 33.75M | 26.27M | 22.6M | 15.08M | 2.4M | 2.07M | -805K |
Interest Expense | 282.82K | 311.6K | 318.4K | 325.4K | 317.07K | 299.27K | 315.28K | 325.1K | 326.03K | 321.95K | 301.58K | 508.34K | 516.28K | 519.47K | 522.64K | 228.18K | 149.63K | 75.19K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 43.26M | 43.99M | 45.55M | 53.29M | 48.57M | 44.58M | 39.65M | 30.49M | 35.3M | 35.36M | 46.47M | 133.81M | 122.07M | 118.4M | 99.08M | 1.73M | 2.07M | -805K |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 25.63K | 25.63K | -66.65K | 25.63K | n/a | -4.72K | 87.56K | -4.72K | -4.72K | n/a | n/a |
Shares Outstanding (Basic) | 9.29M | 9.29M | 9.26M | 9.26M | 9.26M | 9.24M | 5.93M | 5.24M | 5.04M | 5.04M | 5.04M | 4.3M | 4.3M | 4.31M | 4.35M | 4.35M | 4.35M | 4.35M |
Shares Outstanding (Diluted) | 9.29M | 9.29M | 9.26M | 9.26M | 9.26M | 9.24M | 5.93M | 5.24M | 5.04M | 5.04M | 5.04M | 4.3M | 4.3M | 4.58M | 4.35M | 4.35M | 4.35M | 4.35M |
EPS (Basic) | -4 | -3.7 | -3.68 | -6.31 | -6.16 | -6.73 | -7.65 | -5.35 | -5.98 | -5.73 | -4.04 | -6.59 | -5.07 | -4.64 | -4.54 | -0.44 | -0.36 | 0.32 |
EPS (Diluted) | -4 | -3.7 | -3.68 | -6.31 | -6.16 | -6.73 | -7.65 | -5.35 | -5.98 | -5.73 | -4.05 | -6.6 | -5.07 | -4.65 | -4.54 | -0.44 | -0.37 | 0.31 |
EBITDA | -33.92M | -30.38M | -29M | -40.29M | -35.03M | -34.76M | -38.13M | -23.14M | -25.18M | -23.29M | -15.12M | -24.43M | -21.9M | -20.45M | -20.52M | -4.38M | -814K | 1.75M |
EBIT | -36.77M | -33.96M | -33.79M | -45.24M | -40M | -39.57M | -41.88M | -26.86M | -28.83M | -26.82M | -18.41M | -26.8M | -20.12M | -18.19M | -17.86M | -1.72M | -1.39M | 1.48M |
Depreciation & Amortization | 3.35M | 3.59M | 4.79M | 4.95M | 4.97M | 4.81M | 3.75M | 3.72M | 3.65M | 3.54M | 3.29M | 1.79M | 1.3M | 816.63K | 416.41K | 992.41K | 577.37K | 277.22K |